The effectiveness of colistin/levofloxacin compared to colistin/meropenem in the treatment of ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii: a randomized controlled clinical trial

The effectiveness of colistin/levofloxacin compared to colistin/meropenem in the treatment of ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii: a randomized controlled clinical trial

Background and purpose: The treatment of ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii (CRAB) is still a great challenge. This study evaluated the effectiveness of the colistin/levofloxacin regimen compared to the usual colistin/meropenem regimen in the...

Full description

Bibliographic Details
Main Authors:	Mahnaz Momenzadeh, Rasool Soltani, Fatemeh Shafiee, Atousa Hakamifard, Morteza Pourahmad, Saeed Abbasi
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Research in Pharmaceutical Sciences
Subjects:	acinetobacter baumannii; colistin; levofloxacin; meropenem; ventilator-associated pneumonia.
Online Access:	http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2023;volume=18;issue=1;spage=39;epage=48;aulast=Momenzadeh

Similar Items

Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia
by: Jae-Min Park, et al.
Published: (2021-07-01)

The effectiveness and nephrotoxicity of loading dose colistin combined with or without meropenem for the treatment of carbapenem-resistant A. baumannii
by: Wasan Katip, et al.
Published: (2020-08-01)

The Efficacy of Colistin Combined with Amikacin or Levofloxacin against Pseudomonas aeruginosa Biofilm Infection
by: Yuhang Wang, et al.
Published: (2022-10-01)

Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant <i>Acinetobacter baumannii</i> Infection: A Meta-Analysis
by: Chienhsiu Huang, et al.
Published: (2022-06-01)

A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Critically Ill Patients: A Propensity Score-Matched Analysis
by: Wasan Katip, et al.
Published: (2020-09-01)

Effectiveness and Nephrotoxicity of Loading Dose Colistin–Meropenem versus Loading Dose Colistin–Imipenem in the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infection
by: Wasan Katip, et al.
Published: (2022-06-01)

Pharmacodynamics of colistin against Acinetobacter baumannii
by: Mohd Rasidin, Rashizal Sazli
Published: (2017)

Preferential Selection of Low-Frequency, Lipopolysaccharide-Modified, Colistin-Resistant Mutants with a Combination of Antimicrobials in Acinetobacter baumannii
by: Go Kamoshida, et al.
Published: (2022-10-01)

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2021-07-01)

Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
by: Shi H, et al.
Published: (2019-12-01)

Effectiveness of Colistin in carbapenem resistant Acinetobacter baumannii – A systematic review
by: Feroz Ahmed, et al.
Published: (2023-09-01)

Effect of omadacycline alone and in combination with meropenem against carbapenem-resistant Acinetobacter baumannii isolates
by: J. Nicholas O'Donnell, et al.
Published: (2022-06-01)

Molecular characterisation of colistin and carbapenem-resistant clinical isolates of Acinetobacter baumannii from Southeast Europe
by: Ivana Goic-Barisic, et al.
Published: (2023-06-01)

Effect of Colistin, Fosfomycin and Meropenem/Vaborbactam on Carbapenem-Resistant Enterobacterales in Egypt: A Cross-Sectional Study
by: Shrief R, et al.
Published: (2022-10-01)

Colistin Dependency among Colistin-Heteroresistant <i>Acinetobacter baumannii</i> Isolates
by: Hadas Kon, et al.
Published: (2021-12-01)

Risk Factors Associated With Colistin-Resistant Acinetobacter baumannii Infection
by: Hae-Sun Chung, et al.
Published: (2023-06-01)

Mathematical pharmacodynamic modeling for antimicrobial assessment of ceftazidime/colistin versus gentamicin/meropenem combinations against carbapenem-resistant Pseudomonas aeruginosa biofilm
by: Mona Shaban E. M. Badawy, et al.
Published: (2023-07-01)

Genomic investigation unveils colistin resistance mechanism in carbapenem-resistant Acinetobacter baumannii clinical isolates
by: Saranya Vijayakumar, et al.
Published: (2024-02-01)

Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infections: A Preliminary Study
by: Rujipas Sirijatuphat, et al.
Published: (2022-11-01)

Pharmacokinetic/pharmacodynamic (PK/PD) simulation for dosage optimization of colistin and sitafloxacin, alone and in combination, against carbapenem-, multidrug-, and colistin-resistant Acinetobacter baumannii
by: Vipavee Rodjun, et al.
Published: (2023-11-01)

Synergistic Activity of Capsaicin and Colistin Against Colistin-Resistant Acinetobacter baumannii: In Vitro/Vivo Efficacy and Mode of Action
by: Tingting Guo, et al.
Published: (2021-09-01)

In Vitro Synergistic Activity of Antimicrobial Combinations against Carbapenem- and Colistin-Resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i>
by: Paraskevi Mantzana, et al.
Published: (2023-01-01)

In vitro and in vivo synergistic effect of chrysin in combination with colistin against Acinetobacter baumannii
by: Yining Zhao, et al.
Published: (2022-10-01)

Efficacy of colistin and rifampin combination for treatment of ventilator associated pneumonia caused by carbapenem resistant Acinetobacter baumannii: brief report
by: Masoomeh Sofian, et al.
Published: (2020-02-01)

A Randomized Controlled Trial: Colistin Alone or Colistin and Meropenem: Which Is More Effective for the Management of Urinary Tract Infections?
by: Davood Yadegarynia, et al.
Published: (2022-12-01)

Prevalence and Clinical Consequences of Colistin Heteroresistance and Evolution into Full Resistance in Carbapenem-Resistant Acinetobacter baumannii
by: Hadas Kon, et al.
Published: (2023-06-01)

Colistin Resistant A. baumannii: Genomic and Transcriptomic Traits Acquired Under Colistin Therapy
by: Viviana Cafiso, et al.
Published: (2019-01-01)

Two types of colistin heteroresistance in Acinetobacter baumannii isolates
by: Yoon-Kyoung Hong, et al.
Published: (2020-01-01)

In vitro activity of colistin mono- and combination therapy against colistin-resistant Acinetobacter baumannii, mechanism of resistance, and clinical outcomes of patients infected with colistin-resistant A. baumannii at a Thai university hospital
by: Lertsrisatit Y, et al.
Published: (2017-11-01)

Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii
by: Marta Carretero-Ledesma, et al.
Published: (2018-12-01)

Comparative genomics and molecular epidemiology of colistin-resistant Acinetobacter baumannii
by: Jovana Kabic, et al.
Published: (2023-01-01)

Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible <i>Acinetobacter baumannii</i> VAP: Clinical, Pharmacokinetic and Microbiome Features
by: Gennaro De Pascale, et al.
Published: (2023-01-01)

Ineffectiveness of colistin monotherapy in treating carbapenem-resistant Acinetobacter baumannii Pneumonia: A retrospective single-center cohort study
by: Cheon-Hoo Jeon, et al.
Published: (2024-05-01)

Lipopolysaccharide-Deficient Acinetobacter baumannii Due to Colistin Resistance Is Killed by Neutrophil-Produced Lysozyme
by: Go Kamoshida, et al.
Published: (2020-04-01)

Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii
by: Bin Liu, et al.
Published: (2014-07-01)

Investigation of the Synergic Effect of the Colistin/ Sulbactam Combination in Carbapenem-Resistant Acinetobacter baumannii complex Strains with Time-Kill and Checkerboard Methods
by: İmdat KILBAŞ, et al.
Published: (2021-03-01)

Influencing factors of successful eradication of multidrug-resistant Acinetobacter baumannii in the respiratory tract with aerosolized colistin
by: Yu-Mu Chen, et al.
Published: (2014-10-01)

In Vitro Activity of Tigecycline and Colistin against clinical isolates of Acinetobacter baumannii in Hospitals in Tehran and Bandar-Abbas, Iran
by: Shahin najar peerayeh, et al.
Published: (2014-03-01)

In-Vitro Evaluation of Different Antimicrobial Combinations with and without Colistin Against Carbapenem-Resistant Acinetobacter Baumannii
by: Alessandra Oliva, et al.
Published: (2019-03-01)

Colistin and Carbapenem-Resistant <i>Acinetobacter baumannii</i> Aci46 in Thailand: Genome Analysis and Antibiotic Resistance Profiling
by: Nalumon Thadtapong, et al.
Published: (2021-08-01)